Uncategorized 4FOX Ventures have successfully led the USD 6M+ Series A2 round of Artiria Medical Uncategorized Very happy to announce that Dominique Mégret is the new CEO of our portfolio company Ecorobotix Uncategorized Highlights of the Swiss Venture Capital Report 2024 Uncategorized Our portfolio company Ecorobotix has been ranked among the top 10 fastest-growing robotic start-ups in Europe ! 🤖🦾 Uncategorized Our portfolio company Positrigo at the beginning of a new era ! 🚀 Uncategorized Very pleased to welcome Michael De Vivo as the new CEO of our portfolio company 3D2cut SA ! Uncategorized Our portfolio company Aspivix has obtained the CE Mark! 🎉 Uncategorized Very thrilled to welcome Susan Nicholson MD FIDSA & Jessica J. Federer within the Board of Directors of Aspivix. Uncategorized Congratulations to our portfolio company Scailyte for extending its Series A to USD 8 Million! Uncategorized If that is not a proof of an unmet market need, then we are well wondering what is is ! Time to address these needs adequately for the well-being of these millions of womens ! Uncategorized Exciting news: our portfolio company Artiria Medical has obtained the Innosuisse Certificate ! 🏆🚀 Uncategorized A few days ago, the FDA announced the approval of Leqembi, the second anti-amyloid treatment available for Alzheimer’s disease. A third may not be far behind after decades of search. The therapeutic space is thus booming now. Uncategorized There are few words to express the deep pain and sorrow of losing Simon Aspinall, the CEO of Ecorobotix, one of our most succesful portfolio companies. Uncategorized Ecorobotix has just announced the completion of a $52 million (CHF 46 million) funding round Uncategorized Keren Leshem is the new Board Member of our portfolio company Aspivix Uncategorized Guillaume Petit-Pierre, CEO and Co-Founder of Artiria Medical , will be presenting at the Innovation Summit Dublin 2023, one of the most prominent MedTech conference in Europe Uncategorized Our General Partner Bin Sheng was in Biopôle Lausanne to welcome the Hangzhou Delegation and help reinforce collaboration between Switzerland and China Uncategorized Scailyte annouces collaboration with Turnstone Biologics to identify biomarker signatures in solid tumor with TIL therapy Uncategorized Ecorobotix obtains once again the BCorp certification Uncategorized RQM+ has acquired Giotto Compliance from Giotto.AI, previously known as L2F Uncategorized Ecorobotix expanding its global footprint and growing its distribution network in Turkey, Spain, Denmark and Poland Uncategorized Aspivix team obtains the 510(k) clearance from the US FDA admnistration for Carevix, their novel cervical stabilizer that will help millions of American women and that offers an alternative to a painful century-old gynecological tool Uncategorized Swiss start-ups raised close to CHF 4Bn funding in 2022 despite a very tense economical and political environment. The Canton of Vaud attracted the major share of this funding with a record number of exits. Uncategorized Moderna is now recognized as Global Biotech Company of the Year Uncategorized The Swiss parliament made an urgent and necessary decision that paves the way for accepting medical devices certified by the FDA Uncategorized Artiria Medical has been selected as one of the highest rated company pitching at the Tech Tour Future Health event Uncategorized The Swiss Economic Forum has awarded the cleantech scale-up the quality label “SEF.Growth high potential”, which validates Ecorobotix’s high growth strategy Uncategorized 4FOX Ventures took part of the succesful USD 5M closing of the Serie A+ of our portfolio company Aspivix Uncategorized Our portfolio company Ecorobotix won the gold medal in robotics and embedded electronics at the prestigious SIMA Innovation Awards 2022 Uncategorized Our portfolio company Positrigo just secured a first closing of CHF 5.5M for its series B round, welcoming new investors and bringing the total amount raised to date to CHF 13M
Uncategorized Very happy to announce that Dominique Mégret is the new CEO of our portfolio company Ecorobotix
Uncategorized Our portfolio company Ecorobotix has been ranked among the top 10 fastest-growing robotic start-ups in Europe ! 🤖🦾
Uncategorized Very pleased to welcome Michael De Vivo as the new CEO of our portfolio company 3D2cut SA !
Uncategorized Very thrilled to welcome Susan Nicholson MD FIDSA & Jessica J. Federer within the Board of Directors of Aspivix.
Uncategorized Congratulations to our portfolio company Scailyte for extending its Series A to USD 8 Million!
Uncategorized If that is not a proof of an unmet market need, then we are well wondering what is is ! Time to address these needs adequately for the well-being of these millions of womens !
Uncategorized Exciting news: our portfolio company Artiria Medical has obtained the Innosuisse Certificate ! 🏆🚀
Uncategorized A few days ago, the FDA announced the approval of Leqembi, the second anti-amyloid treatment available for Alzheimer’s disease. A third may not be far behind after decades of search. The therapeutic space is thus booming now.
Uncategorized There are few words to express the deep pain and sorrow of losing Simon Aspinall, the CEO of Ecorobotix, one of our most succesful portfolio companies.
Uncategorized Ecorobotix has just announced the completion of a $52 million (CHF 46 million) funding round
Uncategorized Guillaume Petit-Pierre, CEO and Co-Founder of Artiria Medical , will be presenting at the Innovation Summit Dublin 2023, one of the most prominent MedTech conference in Europe
Uncategorized Our General Partner Bin Sheng was in Biopôle Lausanne to welcome the Hangzhou Delegation and help reinforce collaboration between Switzerland and China
Uncategorized Scailyte annouces collaboration with Turnstone Biologics to identify biomarker signatures in solid tumor with TIL therapy
Uncategorized Ecorobotix expanding its global footprint and growing its distribution network in Turkey, Spain, Denmark and Poland
Uncategorized Aspivix team obtains the 510(k) clearance from the US FDA admnistration for Carevix, their novel cervical stabilizer that will help millions of American women and that offers an alternative to a painful century-old gynecological tool
Uncategorized Swiss start-ups raised close to CHF 4Bn funding in 2022 despite a very tense economical and political environment. The Canton of Vaud attracted the major share of this funding with a record number of exits.
Uncategorized The Swiss parliament made an urgent and necessary decision that paves the way for accepting medical devices certified by the FDA
Uncategorized Artiria Medical has been selected as one of the highest rated company pitching at the Tech Tour Future Health event
Uncategorized The Swiss Economic Forum has awarded the cleantech scale-up the quality label “SEF.Growth high potential”, which validates Ecorobotix’s high growth strategy
Uncategorized 4FOX Ventures took part of the succesful USD 5M closing of the Serie A+ of our portfolio company Aspivix
Uncategorized Our portfolio company Ecorobotix won the gold medal in robotics and embedded electronics at the prestigious SIMA Innovation Awards 2022
Uncategorized Our portfolio company Positrigo just secured a first closing of CHF 5.5M for its series B round, welcoming new investors and bringing the total amount raised to date to CHF 13M
